インターネットのニュースを見ているとこんな記事が・・・

中国共産党率いる中国が世界制覇のために生物兵器として開発いた武漢ウイルスの脅威は、現在で、全世界 260,238,440人の人々を感染させ、5,198,292を死に追いやっています。武漢ウイルスは、どこにでおる風邪のウイルスの遺伝子を組み替えて（インドの科学者はSARSの遺伝子が人為的に組み込まれていると最初から指摘）生物兵器として仕立てたもので自己を制御するこなく無制限に変異を繰り返すウイルスです。今日、インターネットのニュースで見た武漢ウイルス関連記事には・・・

Prof Francois Balloux, Professor of Computational Systems Biology and Director, UCL Genetics Institute, UCL, said:

"B.1.1529 is a new lineage that has been found in Botswana that carries an unusual constellation of mutations.

Given the large number of mutations it has accumulated apparently in a single burst, it likely evolved during a chronic infection of an immunocompromised person, possibly in an untreated HIV/AIDS patient.

"It is difficult to know what to make of the carriage of both P681H and N679K.

It is a combination we see only exceptionally rarely.

I suspect it is generally not estable f, but it might be so, in combination with other mutations/deletions.

"I would definitely expect it to be poorly recognised by neutralising antibodies relative to Alpha or Delta.

It is difficult to predict how transmissible it may be at this stage.

"So far, four strains have been sequenced in a region of Sub-Saharan with reasonable surveillance in place.

It may be present in other parts of Africa.

"For the time being, it should be closely monitored and analysed, but there is no reason to get overly concerned, unless it starts going up in frequency in the near future."

On the B.1.628 lineage in the US:

Prof Francois Balloux, Professor of Computational Systems Biology and Director, UCL Genetics Institute, UCL, said:

"B.1.628 has been shown to likely have emerged through an event of recombination rather than sequential accumulation of mutations and deletions.

All coronavirus tend to readily recombine between strains of the same species, and SARS-CoV-2 is likely no exception.

"There have been putative SARS-CoV-2 erecombinant strains f identified before.

Though, this is the first time that there is evidence this happened in a lineage that has been reasonably successful.

"B.1.628 reached a global prevalence of ~0.5% globally during the summer of 2020, but is likely extinct by now.

There is no evidence it more transmissible, virulent or better at evading immune recognition than other SARS-CoV-2 lineages."